CET 9:00-9:20 | Opening Speech
Speakers: Leo Luo & Sy Chyi Yeoh
CET 9:20-9:50 | The cross-border partnership opportunities for biotech companies in Europe and China
Speaker: Dr. Ahmed Bouzidi
CET 09:50-10:20 | How Chinese Medtech company can explore EU market
Speaker: Paolo Guerra
CET 10:20-10:50 | An integrated market access solution and plan to EU Market
Speaker: Sy Chyi Yeoh
CET 10:50-11:30 | Panel discussion and Q&A
Speakers: Leo Luo, Sy Chyi Yeoh, Dr. Ahmed Bouzidi, Paolo Guerra
Leo graduated from Peking University and obtained the master degree of Pharmaceutical Engineering. He has 23 years of experiences of the international business development in the pharmaceutical industry, and as the project leader he once managed more than 10 global transaction deals with the models of IP license-in, JV and distribution rights granting. Before founding Angine, Leo once was the Director and head of International Business Development for two pharma public company.
Prior to joining TRINOMAB EU, Ahmed was CEO of Vaxeal Holding SA, biotech SME specialized in Immuno-Oncology, bringing the company to Pre-IPO stage. He also was President of the European Biopharmaceutical Enterprises (EBE), and board member of Vaccines Europe (VE). His executive management experience in the biotechnology industries spans more than 25 years.
Business Development Director with over 15 years of experience in the pharmaceutical industry accomplished at identifying and developing new services, opportunities and marketing strategies catering to the European and APAC market.
Has an in-depth understanding of pharmaceutical industry, health authorities' policies, regulatory compliance impact on market and companies.
Hands on experience in working with major pharma companies from Greater China deploying solutions for them to enter into EU/US market.
Paolo Guerra has more than 15 years of experience in medical devices, strong experience in Management of teams targeted to results, in timely manner with periodic detailed reporting.
Strong skills in both regulatory and quality activities not limited to medical devices, but either including combined devices.
Subscribe to the latest newsletter of Virtual Expo Connect